The Ministry of Social Affairs and Health (hereinafter ”STM”) and Finnish institute for health and welfare (hereinafter "THL" or “Customer” ) requested tenders for Live Attenuated Influenza Vaccine (LAIV) belonging to the National Vaccination Programme in Finland.

The contract period is one year (influenza season 2023-2024). The procurement contains three options to extend the contract for the periods concerning influenza seasons 2024-2025, 2025-2026 and 2026-2027.

The purpose of STM and the Customer was to procure Live Attenuated Quadrivalent Seasonal Influenza Vaccine (LAIV) belonging to the National Vaccination Programme in Finland. The tendered vaccine must be suitable for children aged between two and six years old.

More information about National Vaccination Programme and vaccinations can be found on the website of the National Institute for Health and Welfare:

https://thl.fi/en/web/infectious-diseases-and-vaccinations/vaccines-a-to-z/influenza-vaccine/nasal-spray-influenza-vaccine-for-children